organization · Reporting owner
GREENBELT CORP /NY
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Lineage Cell Therapeutics, Inc.BTX · Entity 6045 | See Remarks | December 31, 2017 | February 15, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Lineage Cell Therapeutics, Inc.
Report date December 31, 2017 · Filed February 15, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, no par valueSEC Table I · non-derivative | Direct | 1,043,346 |
Reported balance
After 2017-12-01 transaction · row 1
1 source rowRow 1 · 2017-12-01 · Gift · Disposed 100,000 · Balance 1,043,346 F1: During December 2017, Greenbelt Corp. gifted a total of 100,000 common shares to certain charitable organizations. |
Filing footnotes · ownership attribution and instrument terms
F1: During December 2017, Greenbelt Corp. gifted a total of 100,000 common shares to certain charitable organizations.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2017 Filed Feb 15, 2018 02:45 UTC | Lineage Cell Therapeutics, Inc. BTX · Entity 6045 | GiftCommon Shares, no par value | 100,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-010225 · doc5.xml · nonDerivative · entry 1 GREENBELT CORP /NY · CIK 0000938354 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,043,346 F1 · date: During December 2017, Greenbelt Corp. gifted a total of 100,000 common shares to certain charitable organizations. F1 · price: During December 2017, Greenbelt Corp. gifted a total of 100,000 common shares to certain charitable organizations. Read SEC document |
| January 03, 2017 Filed Jan 7, 2017 02:52 UTC | Lineage Cell Therapeutics, Inc. BTX · Entity 6045 | OtherCommon Shares, no par value | 238,459 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-002816 · doc4.xml · nonDerivative · entry 1 GREENBELT CORP /NY · CIK 0000938354 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,143,346 F1 · date: Distribution to a shareholder in partial redemption of their shares of Greenbelt Corp. None of Mr. Kingley's shares in Greenbelt Corp. have been redeemed. F1 · price: Distribution to a shareholder in partial redemption of their shares of Greenbelt Corp. None of Mr. Kingley's shares in Greenbelt Corp. have been redeemed. Read SEC document |
| December 01, 2016 Filed Jan 7, 2017 02:40 UTC | Lineage Cell Therapeutics, Inc. BTX · Entity 6045 | GiftCommon Shares, no par value | 69,300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-002809 · doc5.xml · nonDerivative · entry 1 GREENBELT CORP /NY · CIK 0000938354 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,381,805 F1 · date: During December 2016, Greenbelt Corp. gifted a total of 69,300 common shares to certain charitable organizations. F1 · price: During December 2016, Greenbelt Corp. gifted a total of 69,300 common shares to certain charitable organizations. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.